Submitting for consideration and confirmation to the Board of Directors of the Hawai'i Health Systems Corporation, Gubernatorial Nominee, LISA RANTZ, for a term to expire 06-30-2029.

2025 Regular Session

Lisa Rantz confirmed to the Hawaii Health Systems Corporation Board through June 30, 2029, by Senate advice and consent (25-0), adding a new member to the board.

Confirmed. Ayes, 25. Aye(s) with reservations: none. Noes, 0 (none). Excused, 0 (none).

#boardofdirectorsofthehawai'ihealthsystemscorporation

GM699 — Confirmation of Lisa Rantz to the Hawaiʻi Health Systems Corporation Board of Directors

Overview

GM699 concerns the nomination and confirmation of Lisa Rantz to serve on the Board of Directors of the Hawaiʻi Health Systems Corporation (HHSC). The term for the appointment is set to expire on June 30, 2029. The measure reflects the constitutional requirement for Senate confirmation of gubernatorial nominees for key state boards and commissions.

Purpose and Intent

To submit for consideration and confirmation the Governor’s nomination of Lisa Rantz to the HHSC Board.

To establish and fix the appointment term: expiration of June 30, 2029.

To authorize the Senate to advise and consent per Article V, Section 6 of the Hawaiʻi State Constitution.

Nominee Details

Nominee: Lisa Rantz

Position: Member, Board of Directors, Hawaiʻi Health Systems Corporation

Term: Through June 30, 2029

Nomination transmitted by the Governor via Gov. Msg. No. GM699 (February 28, 2025)

Key Provisions and Provisions’ Impacts

The core provision is the gubernatorial appointment of a Board member subject to Senate confirmation.

No changes to HHSC governance are enacted beyond the addition of a confirmed Board member.

The confirmation process provides Senate oversight and consent for the appointment, aligning with constitutional requirements.

Affected Parties and Stakeholders

Hawaiʻi Health Systems Corporation and its network of facilities are directly affected through changes to its Board composition.

Lisa Rantz, as a gubernatorial nominee, is the principal individual affected.

The Hawaii State Senate (via the confirmation process) and the Governor (via appointment) are the key procedural actors.

Procedural Timeline and Status

Introduced: March 4, 2025

Referred to: Senate Committee on Health (HHS) on March 4, 2025

Public Hearing: Scheduled for April 7, 2025 (1:00 PM, Conference Room 225 & Videoconference)

Committee Action: April 7, 2025 — HHS recommends Advise and Consent (5 Aye; 0 Noes; 0 Excused)

Reported: April 14, 2025 — Stand. Com. Rep. No. 1868 with recommendation to Advise and Consent

One-Day Notice: April 14, 2025

Senate Hearing/Consent: April 15, 2025 — Confirmed by the Senate with Ayes 25, Noes 0, Excused 0

Status: Confirmed (Ayes 25; no reservations; no abstentions)

Summary

GM699 implements the confirmation of Lisa Rantz to the HHSC Board for a term ending in 2029. It follows the standard gubernatorial nomination and Senate confirmation process, with a clear timeline of hearings and a final Senate vote of 25–0 in approval. The outcome results in an additional confirmed member serving on the HHSC Board, contributing to governance and oversight of Hawaiʻi’s public health system.